rare diseases

<p>📑 Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between 03.05.2026 and 10.05.2026. During this period, 6 new PQs were published and 12 Commission Answers became available. Key themes this week included medical supply chain resilience, cancer prevention, regulation of novel health products, and health data governance. 🧬 Medicines & Regulation ❗ […]</p>

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between 16.02.2026 and 22.02.2026. During this period, 18 new PQs were published and 15 Commission Answers became available. Key themes this week included environmental health and industrial risks, food safety and import controls, and various topics in public health and prevention, such as communicable […]

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between 02.02.2026 and 08.02.2026. During this period, 21 new PQs were published and 10 Commission Answers became available. Key themes this week included public health and prevention, with a focus on non-communicable diseases, mental health, and legacy issues from the COVID-19 pandemic. Other significant […]

This week in EU health policy: Debates on medicines regulation, public health risks like nitrous oxide, health system access, and environmental health links.

This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.